Literature DB >> 17198842

Pulmonary transfusion reactions.

David F Stroncek1.   

Abstract

Transfusion reactions remain a common complication of transfusion therapy; reactions affecting the lungs are some of the most serious. Several different mechanisms are responsible for pulmonary transfusion reactions, and most cause adverse effects in addition to lung injury. Fluid overload can lead to pulmonary edema, antibodies reacting with plasma proteins can cause bronchospasm and anaphylaxis, and particulate matter can produce microemboli. These reactions are well understood and usually can be prevented. Transfusions are also associated with acute lung injury and acute respiratory distress syndrome (ARDS), but their etiology is poorly understood and they remain clinically problematic. Neutrophil antibodies cause some of these serious as well as mild pulmonary reactions, but the exact role of leukocyte antibodies in pulmonary reactions remains unclear. Other blood donor, blood component, and transfusion recipient factors likely play a contributing or modulating role in pulmonary transfusion reactions, but prospective studies are needed to better understand their role.

Entities:  

Mesh:

Year:  2007        PMID: 17198842     DOI: 10.1053/j.seminhematol.2006.09.014

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  3 in total

1.  Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention.

Authors:  Mark A Popovsky
Journal:  Transfus Med Hemother       Date:  2008-03-10       Impact factor: 3.747

Review 2.  Pulmonary transfusion reactions.

Authors:  Jürgen Bux; Ulrich J H Sachs
Journal:  Transfus Med Hemother       Date:  2008-09-18       Impact factor: 3.747

3.  Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.

Authors:  Karen Quillen; Consuelito Medrano; Sharon Adams; Brett Peterson; Julia Hackett; Susan F Leitman; Harvey G Klein; David F Stroncek
Journal:  Transfusion       Date:  2010-09-16       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.